These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 29602229)

  • 21. Gender-Affirming Hormone Therapy for Transgender Men.
    Moravek MB
    Clin Obstet Gynecol; 2018 Dec; 61(4):687-704. PubMed ID: 30285972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory Changes During Gender-Affirming Hormone Therapy in Transgender Adolescents.
    Millington K; Lee JY; Olson-Kennedy J; Garofalo R; Rosenthal SM; Chan YM
    Pediatrics; 2024 May; 153(5):. PubMed ID: 38567424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cystatin C-Based eGFR Changes during Gender-Affirming Hormone Therapy in Transgender Individuals.
    van Eeghen SA; Wiepjes CM; T'Sjoen G; Nokoff NJ; den Heijer M; Bjornstad P; van Raalte DH
    Clin J Am Soc Nephrol; 2023 Dec; 18(12):1545-1554. PubMed ID: 37678248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short- and long-term clinical skin effects of testosterone treatment in trans men.
    Wierckx K; Van de Peer F; Verhaeghe E; Dedecker D; Van Caenegem E; Toye K; Kaufman JM; T'Sjoen G
    J Sex Med; 2014 Jan; 11(1):222-9. PubMed ID: 24344810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: A cohort study.
    Vita R; Settineri S; Liotta M; Benvenga S; Trimarchi F
    Maturitas; 2018 Jan; 107():92-96. PubMed ID: 29169588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variation in sensitivity and rate of change in body composition: steps toward individualizing transgender care.
    van Velzen DM; Nota NM; Simsek S; Conemans EB; T'Sjoen G; den Heijer M
    Eur J Endocrinol; 2020 Nov; 183(5):529-536. PubMed ID: 33071222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does Testosterone Treatment Increase Anger Expression in a Population of Transgender Men?
    Motta G; Crespi C; Mineccia V; Brustio PR; Manieri C; Lanfranco F
    J Sex Med; 2018 Jan; 15(1):94-101. PubMed ID: 29175227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythrocytosis in Gender-Affirming Care With Testosterone.
    Porat AT; Ellwood M; Rodina M; Dianat S
    Ann Fam Med; 2023; 21(5):403-407. PubMed ID: 37748907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review.
    Velho I; Fighera TM; Ziegelmann PK; Spritzer PM
    Andrology; 2017 Sep; 5(5):881-888. PubMed ID: 28709177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
    Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
    Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of testosterone on ovulatory function in transmasculine individuals.
    Taub RL; Ellis SA; Neal-Perry G; Magaret AS; Prager SW; Micks EA
    Am J Obstet Gynecol; 2020 Aug; 223(2):229.e1-229.e8. PubMed ID: 32044312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaginal bleeding and spotting in transgender men after initiation of testosterone therapy: A prospective cohort study (ENIGI).
    Defreyne J; Vanwonterghem Y; Collet S; Iwamoto SJ; Wiepjes CM; Fisher AD; Schreiner T; Heijer MD; T'Sjoen G
    Int J Transgend Health; 2020 Feb; 21(2):163-175. PubMed ID: 32935087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythrocytosis Is Rare With Exogenous Testosterone in Gender-Affirming Hormone Therapy.
    Krishnamurthy N; Slack DJ; Kyweluk M; Cullen O; Kirkley J; Safer JD
    J Clin Endocrinol Metab; 2024 Apr; 109(5):1285-1290. PubMed ID: 38011684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a need for liver enzyme monitoring in people using gender-affirming hormone therapy?
    Stangl TA; Wiepjes CM; Defreyne J; Conemans E; D Fisher A; Schreiner T; T'Sjoen G; den Heijer M
    Eur J Endocrinol; 2021 Apr; 184(4):513-520. PubMed ID: 33524005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Healthcare costs and quality of life outcomes following gender affirming surgery in trans men: a review.
    Defreyne J; Motmans J; T'sjoen G
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):543-556. PubMed ID: 28972413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands.
    de Blok CJM; Wiepjes CM; Nota NM; van Engelen K; Adank MA; Dreijerink KMA; Barbé E; Konings IRHM; den Heijer M
    BMJ; 2019 May; 365():l1652. PubMed ID: 31088823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender affirming hormonal treatment in Danish transgender persons: A nationwide register-based study.
    Glintborg D; Rubin KH; Kristensen SB; Lidegaard Ø; T'Sjoen G; Hilden M; Andersen MS
    Andrology; 2022 Jul; 10(5):885-893. PubMed ID: 35366390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Explorative Prospective Evaluation of Short-Term Subjective Effects of Hormonal Treatment in Trans People-Results from the European Network for the Investigation of Gender Incongruence.
    van Dijk D; Dekker MJHJ; Conemans EB; Wiepjes CM; de Goeij EGM; Overbeek KA; Fisher AD; den Heijer M; T'Sjoen G
    J Sex Med; 2019 Aug; 16(8):1297-1309. PubMed ID: 31230940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of cross-sex hormone treatment on transgender women and men.
    Deutsch MB; Bhakri V; Kubicek K
    Obstet Gynecol; 2015 Mar; 125(3):605-610. PubMed ID: 25730222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-Dose Cyproterone Acetate Treatment for Transgender Women.
    Even Zohar N; Sofer Y; Yaish I; Serebro M; Tordjman K; Greenman Y
    J Sex Med; 2021 Jul; 18(7):1292-1298. PubMed ID: 34176757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.